Losartan Versus Atenolol for the Treatment of Marfan Syndrome
Condition(s):Marfan SyndromeLast Updated:July 12, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Marfan SyndromeLast Updated:July 12, 2012Completed
Condition(s):COVID-19 PneumoniaLast Updated:February 18, 2021Withdrawn
Condition(s):Diabetes Mellitus; HypertensionLast Updated:September 3, 2020Withdrawn
Condition(s):Essential Arterial HypertensionLast Updated:January 19, 2017Withdrawn
Condition(s):HypertensionLast Updated:July 9, 2009Completed
Condition(s):Hypertension; Blood PressureLast Updated:November 21, 2017Unknown status
Condition(s):SARS-CoV-2 InfectionLast Updated:March 24, 2022Terminated
Condition(s):Hermansky-Pudlak Syndrome (HPS); Pulmonary Fibrosis; Oculocutaneous Albinism; Platelet Storage Pool Deficiency; Metabolic DiseaseLast Updated:August 2, 2013Terminated
Condition(s):Proteinuria; Hypertension; End Stage Renal DiseaseLast Updated:February 18, 2009Suspended
Condition(s):HypertensionLast Updated:February 22, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.